DescriptionNuvo Pharmaceuticals Inc is a Canadian-focused healthcare company with a diversified portfolio of commercial products. The Company targets several therapeutic areas, including pain, allergy and dermatology. Its aims to in-license and acquire growth-oriented, complementary products for Canadian and international markets and to out-license select products in overseas markets. The company's head office is located in Mississauga, Ontario, Canada, its overseas operations are located in Dublin, Ireland and its manufacturing facility is located in Varennes, Quebec, Canada. The firm operates in three segments: Commercial Business, Production and Service Business and Licensing and Royalty Business.
Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.
Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.
A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.
What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.
A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.
Latest Press Releases
|Period||Period Low||Period High||Performance|
|1-Month|| 0.77 +5.19% increase |
| 0.90 -10.00% decrease |
| +0.01 (+1.25%) increase |
|3-Month|| 0.72 +12.50% increase |
| 0.97 -16.49% decrease |
| +0.07 (+9.46%) increase |
|52-Week|| 0.43 +88.37% increase |
| 1.20 -32.50% decrease |
| +0.26 (+47.27%) increase |